One of the key challenges in early diagnosis is the diversity of toxins and the wide range of symptoms they can produce, which often mimic other medical conditions. Additionally, there may be limited access to specialized testing facilities and resources, which can delay diagnosis. The rapid evolution of new chemical compounds and synthetic drugs adds another layer of complexity, requiring continuous updates in diagnostic capabilities.
